Laura A Williams
Chief Patient Officer at Ardelyx, Inc. (ARDX); See Remarks at Ardelyx, Inc. (ARDX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.0M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 25SEC | ARDXArdelyx, Inc. | Sell | 3,486374,709 held (−1%) | $3.86 | $13K | -15.0% |
| Aug 25SEC | ARDXArdelyx, Inc. | Sell | 3,089371,620 held (−1%) | $3.86 | $12K | -15.0% |
| Aug 25SEC | ARDXArdelyx, Inc. | Sell | 2,430369,190 held (−1%) | $3.86 | $9K | -15.0% |
| Aug 25SEC | ARDXArdelyx, Inc. | Sell | 1,734367,456 held (−0%) | $3.86 | $7K | -15.0% |
| Jun 22SEC | ARDXArdelyx, Inc. | Sell Plan | 81,898378,195 held (−18%) | $5.99 | $491K | -45.2% |
| May 22SEC | ARDXArdelyx, Inc. | Sell | 1,503434,579 held (−0%) | $6.27 | $9K | -47.7% |
| May 22SEC | ARDXArdelyx, Inc. | Sell | 2,157432,422 held (−0%) | $6.27 | $14K | -47.7% |
| May 22SEC | ARDXArdelyx, Inc. | Sell | 1,911430,511 held (−0%) | $6.27 | $12K | -47.7% |
| May 22SEC | ARDXArdelyx, Inc. | Sell | 1,418429,093 held (−0%) | $6.27 | $9K | -47.7% |
| Feb 23SEC | ARDXArdelyx, Inc. | Sell | 7,192437,066 held (−2%) | $5.87 | $42K | -44.1% |
| Feb 23SEC | ARDXArdelyx, Inc. | Sell | 984436,082 held (−0%) | $5.71 | $6K | -42.6% |
| Jan 9SEC | ARDXArdelyx, Inc. | Sell Plan | 50,000361,563 held (−12%) | $6.98 | $349K | -53.0% |
| Nov 25SEC | ARDXArdelyx, Inc. | Sell | 6,426359,896 held (−2%) | $5.54 | $36K | -40.8% |
- Sell
Chief Patient Officer Laura A Williams sold $491K of ARDX at $5.99 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Patient Officer Laura A Williams sold $349K of ARDX at $6.98 — pre-scheduled 10b5-1 plan sale.